Basics |
Company: |
Crinetics Pharmaceuticals, Inc. |
IPO Date: |
July 16, 2018 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$3.43B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.66 | 2.73%
|
Avg Daily Range (30 D): |
$1.05 | 2.42%
|
Avg Daily Range (90 D): |
$1.13 | 2.19%
|
Institutional Daily Volume |
Avg Daily Volume: |
.3M |
Avg Daily Volume (30 D): |
.79M |
Avg Daily Volume (90 D): |
.63M |
Trade Size |
Avg Trade Size (Sh.): |
65 |
Avg Trade Size (Sh.) (30 D): |
57 |
Avg Trade Size (Sh.) (90 D): |
51 |
Institutional Trades |
Total Inst.Trades: |
2,024 |
Avg Inst. Trade: |
$2.34M |
Avg Inst. Trade (30 D): |
$1.92M |
Avg Inst. Trade (90 D): |
$3.17M |
Avg Inst. Trade Volume: |
.07M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$3.54M |
Avg Closing Trade (30 D): |
$4.39M |
Avg Closing Trade (90 D): |
$7.52M |
Avg Closing Volume: |
103.44K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-3.71
|
$-.96
|
$-.94
|
Diluted EPS
|
$-3.71
|
$-.96
|
$-.94
|
Revenue
|
$ 1.04M
|
$ M
|
$ .4M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -277.91M
|
$ -76.83M
|
$ -74.06M
|
Operating Income / Loss
|
$ -306.77M
|
$ -87.8M
|
$ -82.78M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 174.47M
|
$ 15.11M
|
$ -93.76M
|
PE Ratio
|
|
|
|
|